RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bausch Health Companies - Stock

Bausch Health Companies Stocks 2024

Bausch Health Companies Stocks

364.9 M

Ticker

BHC.TO

ISIN

CA0717341071

WKN

A2JQ1X

In 2024, Bausch Health Companies had 364.9 M outstanding stocks, a 0% change from the 364.9 M stocks in the previous year.

The Bausch Health Companies Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2029e364.9
2028e364.9
2027e364.9
2026e364.9
2025e364.9
2024e364.9
2023364.9
2022362
2021358.9
2020355
2019352
2018351
2017352
2016347
2015343
2014342
2013321
2012305
2011326
2010196
2009159
2008160
2007161
2006160
2005160
2004159

Bausch Health Companies shares outstanding

The number of shares was Bausch Health Companies in 2023 — This indicates how many shares 364.9 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Bausch Health Companies earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Bausch Health Companies's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Bausch Health Companies’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Bausch Health Companies's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Bausch Health Companies Aktienanalyse

What does Bausch Health Companies do?

Bausch Health Companies Inc is a Canadian pharmaceutical company that was founded in 2013. However, the company's history dates back to 1853 when John Jacob Bausch and Henry Lomb founded their own company in the USA. This company specialized in optical products, particularly eyeglass frames and lenses. Over the years, the company expanded its product range and also became involved in the production of contact lenses in the 1960s. In the 1970s, the company began to focus on the medical devices sector and expanded in this area through various acquisitions. In the 1990s, the company also established itself in the pharmaceutical sector by building various channels for the distribution of medications. In 2013, the company was renamed and restructured due to financial problems, and in the future, it operated under the name Bausch Health Companies Inc. The company's business model is based on the development, manufacture, and marketing of products in the medical and ophthalmology fields. The company works closely with various institutions such as doctors, pharmacies, and hospitals to ensure that its products are used optimally. The company operates in various areas, including: - Ophthalmology: Bausch Health Companies offers various products in the field of ophthalmology, including contact lenses, eye drops, and other medications that can be used to treat eye diseases such as cataracts or glaucoma. - Dermatology: The company also develops and markets products in the field of dermatology, including medications for the treatment of acne, rosacea, and psoriasis. - Gastroenterology: Bausch Health Companies also produces medications for the treatment of gastrointestinal diseases, such as medications for ulcers or inflammatory bowel diseases. - Neurology: The company manufactures medications for the treatment of neurological disorders, such as epilepsy or migraines. - Urology: Bausch Health Companies also offers products in the field of urology, including medications for the treatment of urinary tract infections or bladder problems. One of the most well-known products of Bausch Health Companies is the brand Bausch + Lomb, which operates in the field of ophthalmology and offers various contact lenses and eye drops. Another well-known product is Jublia, a medication for nail fungus. Overall, Bausch Health Companies is a leading company in the field of medicine and ophthalmology with a long history. With its diverse range of medications and products, it offers effective and reliable solutions for the treatment of various conditions to patients worldwide. Bausch Health Companies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Bausch Health Companies's Shares Outstanding

Bausch Health Companies's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Bausch Health Companies’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Bausch Health Companies’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Bausch Health Companies’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Bausch Health Companies Stock

How many stocks are there of Bausch Health Companies?

The current number of stocks of Bausch Health Companies is 364.9 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Bausch Health Companies are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Bausch Health Companies evolved in recent years?

The number of shares of Bausch Health Companies has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Bausch Health Companies as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Bausch Health Companies?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Bausch Health Companies pay?

Over the past 12 months, Bausch Health Companies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bausch Health Companies is expected to pay a dividend of 0 USD.

What is the dividend yield of Bausch Health Companies?

The current dividend yield of Bausch Health Companies is .

When does Bausch Health Companies pay dividends?

Bausch Health Companies pays a quarterly dividend. This is distributed in the months of April, June, September, December.

How secure is the dividend of Bausch Health Companies?

Bausch Health Companies paid dividends every year for the past 6 years.

What is the dividend of Bausch Health Companies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bausch Health Companies located?

Bausch Health Companies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bausch Health Companies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bausch Health Companies from 12/22/2010 amounting to 1 USD, you needed to have the stock in your portfolio before the ex-date on 11/10/2010.

When did Bausch Health Companies pay the last dividend?

The last dividend was paid out on 12/22/2010.

What was the dividend of Bausch Health Companies in the year 2023?

In the year 2023, Bausch Health Companies distributed 0 USD as dividends.

In which currency does Bausch Health Companies pay out the dividend?

The dividends of Bausch Health Companies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bausch Health Companies stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Bausch Health Companies

Our stock analysis for Bausch Health Companies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bausch Health Companies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.